Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

PASG Passage Bio Inc

0,6143

0,0173 (2,90%)

16 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Passage Bio (NASDAQ:PASG)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Passage Bio Charts.

Passage Bio (NASDAQ:PASG)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Passage Bio Charts.

News Passage Bio Inc

Form 8-K - Current report
Freitag 10 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates
Freitag 10 Januar 2025 (6 Tage vor) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
Donnerstag 24 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 2 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
Montag 23 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Passage Bio Inc News-Artikel

Deutsche Telekom

Deutsche Lufthansa

Health Care Select Sector

Invesco QQQ Trust Series 1

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen